Orchid Chemicals gains post USFDA inspection

MUMBAI: Orchid Chemicals & Pharmaceuticals’ manufacturing facility at Alathur, Chennai has been re-inspected by the USFDA. The facility manufactures range of oral and sterile Cephalosporin API and caters to markets like USA, Europe and Japan.

The stock was at Rs 241.15, up 4.15 per cent on the NSE. It touched a high of Rs 249.35 and low of Rs 235.10 in trade so far.